Retention but significant reduction of BCR-ABL transcript in hematopoietic stem cells in chronic myelogenous leukemia after imatinib therapy

[1]  M. Talpaz,et al.  Getting to the stem of chronic myeloid leukaemia , 2008, Nature Reviews Cancer.

[2]  I. Weissman,et al.  Identification of a hierarchy of multipotent hematopoietic progenitors in human cord blood. , 2007, Cell stem cell.

[3]  J. Goldman.  How I treat chronic myeloid leukemia in the imatinib era. , 2007, Blood.

[4]  M. Deininger.  Optimizing therapy of chronic myeloid leukemia. , 2007, Experimental hematology.

[5]  C. Eaves,et al.  The challenges of targeting chronic myeloid leukemia stem cells. , 2007, Clinical lymphoma & myeloma.

[6]  B. Brors,et al.  Molecular signature of CD34+ hematopoietic stem and progenitor cells of patients with CML in chronic phase , 2007, Leukemia.

[7]  T. Holyoake,et al.  Stem cells in chronic myeloid leukaemia. , 2007, Cancer biomarkers : section A of Disease markers.

[8]  Francisco Cervantes,et al.  Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. , 2006, The New England journal of medicine.

[9]  K. Ishizawa,et al.  Dose modification of imatinib by monitoring the level of BCR-ABL transcript in chronic myelogenous leukemia. , 2006, The Tohoku journal of experimental medicine.

[10]  Ingo Roeder,et al.  Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications , 2006, Nature Medicine.

[11]  Francisco Cervantes,et al.  Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. , 2006, Blood.

[12]  Simona Soverini,et al.  Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results. , 2006, Blood.

[13]  H. Kantarjian,et al.  New Strategies in Chronic Myeloid Leukemia , 2006, International journal of hematology.

[14]  I. Weissman,et al.  The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Martin A. Nowak,et al.  Dynamics of chronic myeloid leukaemia , 2005, Nature.

[16]  F. Costa,et al.  Outcome of four patients with chronic myeloid leukemia after imatinib mesylate discontinuation , 2005 .

[17]  H. Kantarjian,et al.  Discontinuation of imatinib therapy after achieving a molecular response. , 2004, Blood.

[18]  Laurie E Ailles,et al.  Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML. , 2004, The New England journal of medicine.

[19]  C. Sawyers,et al.  Targeted cancer therapy , 2004, Nature.

[20]  M. Slovak,et al.  Persistence of malignant hematopoietic progenitors in chronic myelogenous leukemia patients in complete cytogenetic remission following imatinib mesylate treatment. , 2003, Blood.

[21]  Irving L. Weissman,et al.  Prospective isolation of human clonogenic common myeloid progenitors , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Mackinnon,et al.  Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia , 1999, Leukemia.

[23]  T. Holyoake,et al.  Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro. , 2002, Blood.

[24]  Branford,et al.  Monitoring chronic myeloid leukaemia therapy by real‐time quantitative PCR in blood is a reliable alternative to bone marrow cytogenetics , 1999, British journal of haematology.

[25]  C. Eaves,et al.  Differences between normal and cml stem cells: Potential targets for clinical exploitation , 1998, Stem cells.

[26]  J. Denburg,et al.  Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. , 1985, Blood.

[27]  M. Ogawa,et al.  Identification of pure and mixed basophil colonies in culture of human peripheral blood and marrow cells , 1984 .

[28]  Eaves Ac,et al.  Abnormalities in the erythroid progenitor compartments in patients with chronic myelogenous leukemia (CML). , 1979 .